Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List BAF-312(SiponiMod)

BAF-312(SiponiMod) synthesis

10synthesis methods
Siponimod, also known as BAF-312, is a a potent and orally selective S1P Receptor Modulator with EC50 value of 0.39nM for S1P1 receptors and 0.98nM for S1P5 receptors, respectively. Development of sphingosine-1-phosphate receptor 1 (S1P1) modulators to dampen inflammation and its sequelae is becoming increasingly promising for treating medical conditions characterized by significant immunopathology. Synthetic Description Reference: Pan, Shifeng; Gray, Nathanael S.; Gao, Wenqi; Mi, Yuan; Fan, Yi; Wang, Xing; Tuntland, Tove; Che, Jianwei; Lefebvre, Sophie; Chen, Yu; Chu, Alan; Hinterding, Klaus; Gardin, Anne; End, Peter; Heining, Peter; Bruns, Christian; Cooke, Nigel G.; Nuesslein-Hildesheim, Barbara. Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator. ACS Medicinal Chemistry Letters. Volume 4. Issue 3. Pages 333-337. Journal; Online Computer File. (2013). Synthetic Description Reference: Zhang, Chengzhi; Chakma, Justin. Preparation of deuterium-substituted azetidine compounds as sphingosine 1-phosphate receptor. Assignee Auspex Pharmaceuticals, Inc., USA. WO 2017120124. (2017).
Synthetic Routes
  • ROUTE 1
  • 202112076530059143.jpg

    Reference: Pan, Shifeng; Gray, Nathanael S.; Gao, Wenqi; Mi, Yuan; Fan, Yi; Wang, Xing; Tuntland, Tove; Che, Jianwei; Lefebvre, Sophie; Chen, Yu; Chu, Alan; Hinterding, Klaus; Gardin, Anne; End, Peter; Heining, Peter; Bruns, Christian; Cooke, Nigel G.; Nuesslein-Hildesheim, Barbara. Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator. ACS Medicinal Chemistry Letters. Volume 4. Issue 3. Pages 333-337. Journal; Online Computer File. (2013).

  • ROUTE 2
  • 202112070165800516.jpg

    Reference: Zhang, Chengzhi; Chakma, Justin. Preparation of deuterium-substituted azetidine compounds as sphingosine 1-phosphate receptor. Assignee Auspex Pharmaceuticals, Inc., USA. WO 2017120124. (2017).

  • ROUTE 3
  • 202112075021449168.jpg

    Gallou, Fabrice; Sedelmeier, Joerg Matthias; Vogel, Caspar. (Assignee: Novartis AG, Switz). Process for preparing N-(4-cyclohexyl-3-trifluoromethylbenzyloxy)acetimidic acid ethyl ester. WO 2013113915 (2013).

202112076530059143.jpg

Reference: Pan, Shifeng; Gray, Nathanael S.; Gao, Wenqi; Mi, Yuan; Fan, Yi; Wang, Xing; Tuntland, Tove; Che, Jianwei; Lefebvre, Sophie; Chen, Yu; Chu, Alan; Hinterding, Klaus; Gardin, Anne; End, Peter; Heining, Peter; Bruns, Christian; Cooke, Nigel G.; Nuesslein-Hildesheim, Barbara. Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator. ACS Medicinal Chemistry Letters. Volume 4. Issue 3. Pages 333-337. Journal; Online Computer File. (2013).

1230487-01-0 Synthesis
Benzaldehyde, 4-[(1E)-1-[[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]imino]ethyl]-2-ethyl-

1230487-01-0
13 suppliers
inquiry

36476-78-5 Synthesis
3-Azetidinecarboxylic acid

36476-78-5
411 suppliers
$6.00/1g

-

Yield:1230487-00-9 89%

Reaction Conditions:

Stage #1: 4-[(1E)-1-([[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]imino)ethyl]-2-ethylbenzaldehyde;3-azetidinecarboxylic acid in methanol at 20 - 25; for 0.5 h;
Stage #2: with methanol;sodium tris(acetoxy)borohydride

Steps:

1 Example 1 : Preparation of amorphous form of compound of formula (I)

26 g of (E)-4-(l-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2- ethylbenzaldehyde and 8.53 g of azetidine-3 -carboxylic acid were suspended in 400 ml of MeOH at 20°C-25°C. The suspension was stirred at 20°C-25°C for 30 minutes. 24.3 g of Sodium triacetoxyborohydride was added in 8 equal portions in 10-15 min intervals. The reaction was finished right after the final portion of the reducing agent was added. The solvent was removed by evaporation and the residue was diluted with 156 ml of water and 312 ml of ethyl acetate. pH of the mixture was adjusted by addition of 75 ml of 2M aqueous NaOH to approx 6 at 20°C-25°C. The phases were separated and the organic phase was washed with 60 ml of water, dried using MgS04 and filtered. To the filtrate was added 170 ml of absolute EtOH , the solution was concentrated to the of the original volume. The mixture was again dried using MgSCH, filtered and concentrated to amount of 140 g. 170 ml of absolute EtOH absolute was added and the mixture was concentrated to amount of 140 g. 170 ml of absolute EtOH and 2.4 g of activated charcoal were added and the suspension was agitated for 30 min. The suspension was filtered and the filtrate was concentrated to amount 50 g. To this oily residue, 100 ml of n-heptane was added and the solution was again concentrated to amount 50 g. 100 ml of n-heptane was added and the solution was concentrated to dryness. The formed foam was dried to provide foam that can be crushed to white solid amorphous compound of formula (I), 28.22 g (89% of theoretical yield), 98.5% purity (HPLC in).

References:

WO2020/208167,2020,A1 Location in patent:Page/Page column 14; 15

1418144-63-4 Synthesis
4’-(Hydroxymethyl)-3’-vinylacetophenone

1418144-63-4
6 suppliers
inquiry

BAF-312(SiponiMod) Related Search: